News | December 07, 2025
Paradigm Health to acquire Flatiron’s clinical research business
It's an acquisition that aims at forming one of the US's largest oncology trial networks
It's an acquisition that aims at forming one of the US's largest oncology trial networks
NAEH can cause heavy or abnormal bleeding and, if left untreated, may progress to uterine cancer
MRI is particularly valuable in pediatric care due to its non-invasive nature
Biocon will acquire the residual stake held by Mylan (Viatris) for a total consideration of US$ 815 million
VitiPure serves as essential solubilizers, emulsifiers, and bioavailability enhancers in drug formulations
The topical fluralaner solution is cleared for the prevention and treatment of new world screwworm infestation
The one-time CAR T cell infusion now becomes the first and only therapy of its kind cleared for this patient population
Valorum will advance the commercialization and distribution of Armlupeg in the United States
Granules Consumer Health serves as Granules’ front-end division for OTC products in the US
Excelsior aims to make reshoring affordable and strategic, shielding nations from geopolitical disruptions
Subscribe To Our Newsletter & Stay Updated
